Knowledge, innovation, entrepreneurship: the ingredients of economic development.

Our contribution: careful analysis, global perspective, feasible projects

Tel +39 02796630

NEW BOOK: Investing in Science

Massimo Florio, founder and honorary president of CSIL,  Professor of Public Economics at the University of Milan, has recently authored a new book published by MIT Press.

CSIL activities

RI-Paths - Charting Impact Pathways of Investment in Research Infrastructure

CSIL is partner of an H2020 project aimed to develop a model describing the socio-economic impact of research infrastructures and of their related financial investments. Find out more

European Observatory for Clusters and Industrial Change - EOCIC

CSIL is partner of the project EOCIC, aimed to help Europe's regions and countries in designing better and more evidence-based cluster policies and initiatives. Read more

The world market for safety syringes

The outbreak of the Covid-19 pandemic has created additional pressure on the safety syringes makers to expand their manufacturing capacity and satisfy the demand generated by the Covid-19 vaccination campaign. CSIL has recently issued a report aiming to estimate and forecast how these patterns will affect the syringe market.


RI-PATHS Research Infrastructures’ Impact Assessment Toolkit

CSIL  has recently concluded the Horizon 2020 project RI-PATHS: Research Infrastructure ImPact Assessment PaTHwayS. The final results of the project are available online and include a Research Infrastructures’ Impact Assessment Toolkit site


CSIL independent study on “EADs and ETAs: Added value to the construction sector”.

CSIL has prepared an independent study to provide a comprehensive and unbiased understanding of the strengths and challenges of the European Organisation for Technical Assessment (EOTA) route. 
A set of insight identified is available on EOTA's website, along with the full final report.


NEW CIRIEC Working Paper by Massimo Florio

"Biomed Europa: after the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly", a new CIRIEC Working Paper by Massimo Florio, proposes a structural intervention to create an international, interconnected, transparent, science-informed, and publicly-funded research infrastructure for pharmaceutical and biomedical research – BIOMED EUROPA.


NEW publication: The Social Cost-Benefit Analysis of Large Research Infrastructures

Massimo Florio and Chiara Pancotti authored a new open-access paper published on Oxford Research Encyclopedia of Physics.



Milan CBA Summer School

The 10th edition of the Milan Summer School on Cost-Benefit Analysis will be held in 2021.

We will share more details about the event and application process as soon as possible.


Despite the postponement, the organising committee keeps working on the next edition.
We remain committed to offering a unique learning opportunity.

Ex post evaluation of Major Projects

CSIL, together with Ramboll, completed the Ex post evaluation of environmental Major Projects supported by the ERDF and Cohesion Fund between 2000 and 2013. The study is available on the website of the DG REGIO


EBN Innovation Network

EBN logo
In June, CSIL joined the EBN, the international community of smart and specialised organisations. EBN is a network that connects innovators, entrepreneurs and SMEs.


SBCA – Society for Benefit-Cost Analysis

SCBA logo
CSIL is an affiliate organisation of the SBCA, the Society for Benefit-Cost Analysis.